Travere Therapeutics Stock Forecast
Recent Travere Therapeutics Stock Price | Travere Therapeutics Stock Forecast Price | |
$0.00 | NA% |
$0.00 |
Recent Travere Therapeutics Analyst Ratings Breakdown | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | ||||
Buy ratings: | ||||
Hold ratings: | ||||
Sell ratings: | ||||
Strong sell ratings: | ||||
Average rating: |
The presented Travere Therapeutics stock forecast (traded under symbol RTRX), for forward-twelve-months price target as shown at the top of this page, gives you the average Travere Therapeutics stock forecast for forward target price for symbol RTRX, across the analysts covering Travere Therapeutics (RTRX), as reported in data provided by Zacks Investment Research via Quandl.com.
Investors should also take note that the median Travere Therapeutics stock forecast price target (i.e. representing the middle ground number where half of analysts had a higher Travere Therapeutics stock forecast and half had a lower Travere Therapeutics stock forecast) was $ as of (which is a different mathematical metric versus taking the average or mean), while the
highest Travere Therapeutics stock forecast in the analyst group was $, and the lowest Travere Therapeutics stock forecast in the analyst group was
$, with a standard deviation of $. Get the latest Zacks research report on RTRX — FREE
Top Analyst Picks of the Dow
The Top 20 Largest U.S. Stocks By Market Cap
|
Free RTRX Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Strong Buy (3.75 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |